Stay updated with breaking news from Acxp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP – Get Rating) was the target of a significant decrease in short interest in the month of May. As of May 15th, there was short interest totalling 21,200 shares, a decrease of 7.0% from the April 30th total of 22,800 shares. Based on an average daily volume of 31,200 shares, the […]
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP – Get Rating) saw a large decrease in short interest in the month of March. As of March 31st, there was short interest totalling 29,400 shares, a decrease of 52.8% from the March 15th total of 62,300 shares. Currently, 0.3% of the company’s shares are short sold. Based on an average […]
HC Wainwright reiterated their buy rating on shares of Acurx Pharmaceuticals (NASDAQ:ACXP – Get Rating) in a research note issued to investors on Tuesday morning, Benzinga reports. HC Wainwright currently has a $14.00 price target on the stock. Acurx Pharmaceuticals Price Performance ACXP opened at $2.96 on Tuesday. The firm has a 50 day simple […]
HC Wainwright reaffirmed their buy rating on shares of Acurx Pharmaceuticals (NASDAQ:ACXP – Get Rating) in a research report sent to investors on Tuesday morning, Benzinga reports. The brokerage currently has a $14.00 target price on the stock. Acurx Pharmaceuticals Price Performance Acurx Pharmaceuticals stock opened at $2.86 on Tuesday. The company has a market […]
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP – Get Rating) saw a significant increase in short interest in the month of March. As of March 15th, there was short interest totalling 62,300 shares, an increase of 150.2% from the February 28th total of 24,900 shares. Currently, 0.7% of the company’s shares are short sold. Based on an average […]